These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 11244365

  • 21. Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
    Lieberman P, Meltzer EO, LaForce CF, Darter AL, Tort MJ.
    Allergy Asthma Proc; 2011; 32(2):151-8. PubMed ID: 21352639
    [Abstract] [Full Text] [Related]

  • 22. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM, Meltzer EO.
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [Abstract] [Full Text] [Related]

  • 23. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U.
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [Abstract] [Full Text] [Related]

  • 24. A multicenter clinical study of the efficacy and tolerability of azelastine nasal spray in the treatment of seasonal allergic rhinitis: a comparison with oral cetirizine.
    Charpin D, Godard P, Garay RP, Baehre M, Herman D, Michel FB.
    Eur Arch Otorhinolaryngol; 1995 Jan; 252(8):455-8. PubMed ID: 8719584
    [Abstract] [Full Text] [Related]

  • 25. Seasonal rhinitis and azelastine: long- or short-term treatment?
    Ciprandi G, Ricca V, Passalacqua G, Truffelli T, Bertolini C, Fiorino N, Riccio AM, Bagnasco M, Canonica GW.
    J Allergy Clin Immunol; 1997 Mar; 99(3):301-7. PubMed ID: 9058684
    [Abstract] [Full Text] [Related]

  • 26. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I, Jaúregui I, Basomba A, Cadahia A, Feo F, García JJ, Gonzalo MA, Luna I, Rubio M, Vázquez M.
    Allergol Immunopathol (Madr); 1998 Mar; 26(1):9-16. PubMed ID: 9585822
    [Abstract] [Full Text] [Related]

  • 27. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
    Berger WE, White MV, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
    [Abstract] [Full Text] [Related]

  • 29. Azelastine nasal spray in the management of seasonal allergic rhinitis.
    Meltzer EO, Weiler JM, Dockhorn RJ, Widlitz MD, Freitag JJ.
    Ann Allergy; 1994 Apr; 72(4):354-9. PubMed ID: 7908778
    [Abstract] [Full Text] [Related]

  • 30. Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients.
    Gawlik R, Jawor B, Rogala B, Parzynski S, DuBuske L.
    Am J Rhinol Allergy; 2013 Apr; 27(6):514-6. PubMed ID: 24274229
    [Abstract] [Full Text] [Related]

  • 31. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
    Pearlman DS, Grossman J, Meltzer EO.
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
    Howland WC, Amar NJ, Wheeler W, Sacks H.
    Int Forum Allergy Rhinol; 2011 Sep; 1(4):275-9. PubMed ID: 22287431
    [Abstract] [Full Text] [Related]

  • 33. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W, Wiseman LR.
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [Abstract] [Full Text] [Related]

  • 34. Comparative efficacy of azelastine nasal spray and terfenadine in seasonal and perennial rhinitis.
    Gastpar H, Nolte D, Aurich R, Brendt P, Enzmann H, Giesemann G, Kunkel G, Petzold U, Renz W, Schata M.
    Allergy; 1994 Mar; 49(3):152-8. PubMed ID: 7911010
    [Abstract] [Full Text] [Related]

  • 35. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 36. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
    Lieberman PL, Settipane RA.
    Allergy Asthma Proc; 2003 Sep; 24(2):95-105. PubMed ID: 12776442
    [Abstract] [Full Text] [Related]

  • 37. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012 Sep; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 38. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis.
    Ratner PH, Findlay SR, Hampel F, van Bavel J, Widlitz MD, Freitag JJ.
    J Allergy Clin Immunol; 1994 Nov; 94(5):818-25. PubMed ID: 7963150
    [Abstract] [Full Text] [Related]

  • 39. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine.
    Stern MA, Wade AG, Ridout SM, Cambell LM.
    Ann Allergy Asthma Immunol; 1998 Oct; 81(4):354-8. PubMed ID: 9809500
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of azelastine nasal spray in the treatment of allergic rhinitis: large scale experience in community practice.
    Wober W, Diez Crespo C, Bähre M.
    Curr Med Res Opin; 1997 Oct; 13(10):617-26. PubMed ID: 9327196
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.